Quantcast

Latest Thymosin Stories

2d560980ea51ec39f836ebd002e3a94d
2011-06-09 05:10:00

A type of stem-like cell has been able to transform adult mouse hearts into functioning heart muscles that are able to repair itself, according to a study published in the journal Nature. Although major advancements in heart disease prevention have reduced the number of people who die from heart attacks, the number of those living with heart failure are on the rise, with more than 750,000 people having the condition in the U.K. alone, reports BBC News. The damage a heart attack causes when...

2011-06-06 12:58:43

Revealing another part of the story of muscle development, Johns Hopkins researchers have shown how the cytoskeleton from one muscle cell builds finger-like projections that invade into another muscle cell's territory, eventually forcing the cells to combine. Such muscle cell fusion, the researchers say, is not only important for understanding normal muscle growth, but also muscle regeneration after injury or disease. The work, they believe, could further development of therapies for muscular...

2010-06-22 01:59:57

The APC protein serves as the colon's guardian, keeping tumors at bay. Now researchers reveal a new function for the protein: helping to renovate the cytoskeleton by triggering actin assembly. The result suggests a second way that mutations in APC could lead to cancer. The study appears online on June 21 in the Journal of Cell Biology (www.jcb.org). A faulty APC gene occurs in more than 80% of colon cancers and is one of the early "gateway" mutations leading to abnormal growth. Researchers...

2010-06-01 19:21:07

A synthetic version of a naturally occurring peptide promoted the creation of new blood vessels and repaired damaged nerve cells in lab animals, according to researchers at Henry Ford Hospital in Detroit. "This successful experiment holds promise for treating clot-induced strokes in humans," says study lead author Daniel C. Morris, M.D., senior staff physician in the Department of Emergency Medicine at Henry Ford Hospital. "Neurorestorative therapy is the next frontier in the treatment of...

2010-01-19 21:46:00

Achieved a 25 percent cure rate for gliobastoma in animal model; call for trials to begin in humans Providence, RI "“ New research at Rhode Island Hospital has identified a treatment in animal models for glioblastomas "“ deadly brain tumors which, once diagnosed, offer a poor prognosis and relatively short life expectancy. Using a synthetic form of a naturally-occurring hormone combined with chemotherapy, researchers were able to inhibit tumor growth and achieve a 25 percent cure...

2009-04-11 10:52:28

A protein that the heart produces during its early development reactivates the embryonic coronary developmental program and initiates migration of heart cells and blood vessel growth after a heart attack, researchers at UT Southwestern Medical Center have found. The molecule, Thymosin beta-4 (TB4), is expressed by embryos during the heart's development and encourages migration of heart cells. The new findings in mice suggest that introducing TB4 systemically after a heart attack encourages...

2008-11-04 09:00:30

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that J.J. Finkelstein, RegeneRx's president and chief executive officer, will present a company update at the Rodman & Renshaw Annual Global Investment Conference in New York at 10:20 a.m. ET on Tuesday, November 11. To listen and view the presentation investors may either visit RegeneRx's homepage at www.regenerx.com or click on the following link: http://www.wsw.com/webcast/rrshq14/rgn. An archived copy of the presentation...

2008-10-24 09:00:26

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is a major sponsor of "Walk a Mile in My Shoes," the signature event of National Epidermolysis Bullosa (EB) Awareness Week. The "Walk a Mile in My Shoes" program coordinates events that include rallies, meetings and walk-a-thons in an effort to raise awareness about EB. This year, the EB Medical Research Foundation and DebRA of America are again community charity partners in the program that will take...

2008-10-22 12:00:51

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that J.J. Finkelstein, RegeneRx's president and chief executive officer, will present a company update at the 7th Annual BIO Investor Forum in San Francisco, CA, on Thursday, October 30, 2008 at 2:00 p.m. ET. To listen and view the presentation investors may either visit RegeneRx's homepage at www.regenerx.com or click on the following link: http://phx.corporate-ir.net/phoenix.zhtml?c=144396&p=IROL-...

2008-10-01 09:00:09

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (TB4) peptide formulated as an inhaled therapeutic agent to address this patient population. CF is a life-threatening, hereditary disease that impairs the patient's ability to breathe due to the accumulation of thick and sticky mucus secretions in the airways...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related